Clarapath, a New York-based medical robotics company, acquired Crosscope, a Mountain View, CA-based digital pathology company.
The amount of the deal was not disclosed.
The acquisition combines Clarapath’s SectionStar, an automated, all-in-one tissue sectioning and transfer system with Crosscope’s workflow and computational pathology tools enabling labs to deliver faster, cost effectively, and at higher quality. The deal includes a team with experience in AI, pathology, and medical software development that will join the Clarapath organization.
Led by CEO Dr. Jayendra Shinde, Crosscope provides the Crosscope Dx software, a digital pathology platform to facilitate deploying scalable Artificial Intelligence and Computational Pathology tools to empower pathology laboratories with precision diagnostics.
Led by CEO Eric Feinstein, Clarapath is a medical robotics company that develops tools and workflow solutions to improve outcomes and reduce costs in clinical and non-clinical pathology. Its SectionStar provides automated sectioning for non-clinical and clinical pathology laboratories.
Clarapath is headquartered and runs its medical device development in Hawthorne, NY. It also has a CLIA-certified Clinical Research Organization (CRO) that serves clinical and research organizations by processing tissue, performing whole slide imaging, and providing automated image processing based in New York City at the New York Genome Center.
FinSMEs
28/02/2023